Medpace Holdings, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Medpace Holdings, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 96% of Healthcare companies in United States.
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 16.8 times. Higher than 96% of Healthcare companies in United States.
- Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 88% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
$154Over the last 3 years, every $100 of reported profit came with $154 of operating cash.
Higher than 53% of Healthcare companies in United States.
Self-Funding Ratio
16.8×Over the last 3 years its own operating cash covered its investment spending (capex) 16.8 times.
Higher than 96% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 96% of Healthcare companies in United States.
Growth Efficiency Ratio
$19Sales grew 73% in 3 years; of every extra $100 of sales, $19 became extra profit.
Higher than 50% of Healthcare companies in United States.
Asset Productivity Ratio
+73% / +46%In 3 years sales changed by +73% while total assets changed by +46%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
+2%Cash, after subtracting all debt, equals 2% of its market value (net cash).
Lower than 63% of Healthcare companies in United States.
Tangible Assets Ratio
65%Of every $100 the company owns, $65 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 66% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 88% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Medpace Holdings, Inc. owes $0.79 for every $1 it owns. Net profit rose 12% in the year to Dec 2025, and grew 23% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
36.3Investors pay $36.3 for every $1 of Medpace Holdings, Inc.'s yearly profit, higher than 66% of Healthcare companies in United States.
P/B ratio
42.07The share price is 42.07 times Medpace Holdings, Inc.'s book value per share, higher than 98% of Healthcare companies in United States.
Market cap
$18.3 BThe total market value of all of Medpace Holdings, Inc.'s shares at today's price (share price × number of shares), larger than 93% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$434 MWhat Medpace Holdings, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$15.54Net worth divided by the number of shares. The share price of $653.96 is 42.1 times this, which is the P/B above.
Return on equity (ROE)
162.2%Medpace Holdings, Inc. earned 162.2% on its shareholders' money over the last year, higher than almost all Healthcare companies in United States.
Owes vs Owns
0.79×Medpace Holdings, Inc. owes $0.79 for every $1 it owns (moderate), higher than 77% of Healthcare companies in United States.
Dividend yield
NoneMedpace Holdings, Inc. does not currently pay a dividend.
Revenue growth
+20%Revenue rose 20% in the year to Dec 2025, and grew 20% a year on average over 3 years.
Profit growth
+12%Net profit rose 12% in the year to Dec 2025, and grew 23% a year on average over 3 years.
Profit margin
17.8%Medpace Holdings, Inc. keeps $18 of every $100 of revenue as net profit.
Cash quality
1.6×Cash from Medpace Holdings, Inc.'s business was 1.6× its reported profit in the year to Dec 2025 — its profit turned into cash.
Cash vs debt
Net cashMedpace Holdings, Inc. held $383 M more cash than debt (net cash) at Dec 2025.
Questions
What is Medpace Holdings, Inc.'s P/E ratio?
Investors pay $36.3 for every $1 of Medpace Holdings, Inc.'s yearly profit, higher than 66% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Medpace Holdings, Inc.: $18.3 B ÷ $434 M (30 Jun 2026) = 42.1.
What is Medpace Holdings, Inc.'s return on equity?
Medpace Holdings, Inc. earned 162.2% on its shareholders' money over the last year, higher than almost all Healthcare companies in United States.
How much does Medpace Holdings, Inc. owe compared with what it owns?
Medpace Holdings, Inc. owes $0.79 for every $1 it owns (moderate), higher than 77% of Healthcare companies in United States.
Does Medpace Holdings, Inc. pay a dividend?
No. Medpace Holdings, Inc. does not currently pay a dividend.
Is Medpace Holdings, Inc.'s revenue growing?
Revenue rose 20% in the year to Dec 2025, and grew 20% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.